NLS Pharmaceutics Competitors and Similar CompaniesClear all

NLS Pharmaceutics's competitors and similar companies include Supernus Pharmaceuticals.
NLS Pharmaceutics
NLS Pharmaceutics
NLS Pharmaceutics is a biopharmaceutical company engaged in drug discovery for central nervous system disorders.
Supernus Pharmaceuticals
Supernus Pharmaceuticals
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
Founding Date
Founding Date
2019
Founding Date
2005
Type
Type
Public
Type
Public
Tags
Locations
Locations
Stans, CH HQ
Locations
Rockville, US HQ
Employees
Employees
6
Employees
6527% increase
Valuation ($)
Valuation ($)
10.2 m
Valuation ($)
1.9 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$719m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$74.6m (FY, 2025)
Gross profit
Gross profit
$2.5m (FY, 2024)
Gross profit
$644.4m (FY, 2025)
Net income
Net income
($2m) (FY, 2024)
Net income
($38.6m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.

View company